Allurion Technologies (ALUR) Total Current Liabilities (2022 - 2026)
Allurion Technologies (ALUR) posted Total Current Liabilities of $37.3 million for Q1 2026, down 3.09% on a QoQ basis from $38.4 million in Q4 2025, and up 134.37% year-over-year from $15.9 million in Q1 2025.
Allurion Technologies (ALUR) Total Current Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies' Total Current Liabilities history runs 5 years deep, the most recent figure standing at $37.3 million for Q1 2026.
- Quarterly Total Current Liabilities rose 134.37% year-over-year to $37.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.3 million (up 134.37% YoY) and the FY2025 annual result came in at $38.4 million, up 103.81% from the prior year.
- Total Current Liabilities was $37.3 million for Q1 2026 at Allurion Technologies, down from $38.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $89.9 million in Q2 2023 and bottomed at $11.6 million in Q2 2025.
- A 5-year average of $43.2 million and a median of $37.3 million in 2026 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities sank 77.94% — and 2026, when it soared 134.37%.
- Allurion Technologies' Total Current Liabilities stood at $75.9 million in 2022, then fell by 13.76% to $65.4 million in 2023, then sank by 71.17% to $18.9 million in 2024, then jumped by 103.81% to $38.4 million in 2025, then fell by 3.09% to $37.3 million in 2026.
- Business Quant data shows ALUR's Total Current Liabilities at $37.3 million in Q1 2026, $38.4 million in Q4 2025, and $11.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 37.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.26 Mn |
| Dec 31, 2025 | 38.45 Mn |
| Sep 30, 2025 | 11.62 Mn |
| Jun 30, 2025 | 11.62 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 18.86 Mn |
| Sep 30, 2024 | 19.24 Mn |
| Jun 30, 2024 | 23.56 Mn |
| Mar 31, 2024 | 66.22 Mn |
| Dec 31, 2023 | 65.43 Mn |
| Sep 30, 2023 | 87.23 Mn |
| Jun 30, 2023 | 89.89 Mn |
| Dec 31, 2022 | 75.87 Mn |